Interest and Uptake ofMC1RTesting for Melanoma Risk in a Diverse Primary Care Population
Author(s) -
Jennifer L. Hay,
Kate Zielaskowski,
K White,
Kimberly A. Kaphingst,
Erika Robers,
Dolores D. Guest,
Andrew L. Sussman,
Yvonne Talamantes,
Matthew Schwartz,
Vivian M. Rodríguez,
Yuelin Li,
Elizabeth Schofield,
Jessica Bigney,
Keith Hunley,
David B. Buller,
Marianne Berwick
Publication year - 2018
Publication title -
jama dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.128
H-Index - 166
eISSN - 2168-6084
pISSN - 2168-6068
DOI - 10.1001/jamadermatol.2018.0592
Subject(s) - medicine , population , skin cancer , genetic testing , randomized controlled trial , test (biology) , cancer , psychological intervention , gerontology , family medicine , environmental health , psychiatry , paleontology , biology
Germline variants in the MC1R gene are common and confer moderate melanoma risk in those with varied skin types. Approaches to precision skin cancer prevention that include genetic information may promote risk awareness and risk reduction in the general population, including Hispanics.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom